(Q44356886)

English

Tumor multiplicity is an independent prognostic factor of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin immunotherapy

scientific article published in October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Tumor multiplicity is an independent prognostic factor of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin immunotherapy (English)

1 reference

Europe PubMed Central

2 December 2017

1 reference

based on heuristic

inferred from title

author name string

Faouzia Ajili

1

1 reference

Europe PubMed Central

2 December 2017

Mohamed Manai

2

1 reference

Europe PubMed Central

2 December 2017

Amine Darouiche

3

1 reference

Europe PubMed Central

2 December 2017

Mohamed Chebil

4

1 reference

Europe PubMed Central

2 December 2017

Samir Boubaker

5

1 reference

Europe PubMed Central

2 December 2017

publication date

1 October 2012

1 reference

Europe PubMed Central

2 December 2017

Ultrastructural Pathology

1 reference

Europe PubMed Central

2 December 2017

36

1 reference

Europe PubMed Central

2 December 2017

5

1 reference

Europe PubMed Central

2 December 2017

320-324

1 reference

Europe PubMed Central

2 December 2017

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

Multivariate analysis of the prognostic factors of primary superficial bladder cancer

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

Could patient age influence tumor recurrence rate in non-muscle-invasive bladder cancer patients treated with BCG immunotherapy?

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guérin (BCG) immunotherapy exist?. analysis of a quarter century of literature

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

Recurrence of primary superficial bladder cancer treated with prophylactic intravesical Tokyo 172 bacillus Calmette-Guérin: a long-term follow-up.

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

Differences in tumor characteristics and prognosis in newly diagnosed Ta, T1 urothelial carcinoma of bladder according to patient age.

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

1 reference

https://api.crossref.org/works/10.3109%2F01913123.2012.681833

21 January 2018

Identifiers

10.3109/01913123.2012.681833

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44356886&oldid=2019746675"